Form 4: Molina Healthcare Director Richard Zoretic Receives Stock Grant

Director Richard Zoretic received a stock grant from Molina Healthcare's 2019 Equity Incentive Plan.

Summary

• Richard Zoretic, a director of Molina Healthcare, Inc., received a stock grant on October 1, 2024.
• The grant consisted of 161 shares of common stock, awarded under the company's 2019 Equity Incentive Plan.
• The grant is part of the annual equity award for directors, valued at $220,000 per year, with quarterly installments of $55,000.
• The number of shares granted was determined based on the closing price of Molina Healthcare's common stock on October 1, 2024, which was $341.91.
• Following the transaction, Zoretic beneficially owns 6,808 shares indirectly through a revocable living trust.

Sentiment

Score: 7

Explanation: The document is a routine disclosure of a director's stock grant, which is a standard practice. The sentiment is neutral to slightly positive as it reflects ongoing director compensation.

Positives

• The equity grant aligns the director's interests with those of the shareholders.
• The grant is part of a pre-determined equity incentive plan, providing transparency and predictability.

Industry Context

Equity grants to directors are a common practice in publicly traded companies to incentivize and align their interests with those of shareholders. The size and frequency of these grants can vary depending on the company's compensation policies and industry standards.

Comparison to Industry Standards

• Director compensation packages, including equity grants, vary widely across the healthcare industry.
• Companies like UnitedHealth Group, Anthem (now Elevance Health), and Cigna also provide equity-based compensation to their directors.
• The specific amount and structure of these grants depend on factors such as company size, performance, and governance practices.
• A $220,000 annual equity award is within a reasonable range for directors of a company the size of Molina Healthcare, but a detailed benchmarking analysis would be required to determine if it is above or below average.

Stakeholder Impact

• The stock grant aligns the director's interests with those of the shareholders, potentially leading to better decision-making.
• The grant has a minor dilutive effect on existing shareholders.

Key Dates